Jan 11, 2023 / 03:30PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Good morning, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team here at JPMorgan. And today, I'm joined by Jim Davis and the rest of the Quest Diagnostics team.
So similar to most of the other sessions that you've been attending, this will be a 40-minute session, the first half being a 20-minute presentation by management, followed by 20 minutes of Q&A. For those of you listening online, feel free to submit a question via the webcast function. Otherwise, for those of you in the room, if you have a question, please raise your hand and we have mic runners throughout the room. With that...
James E. Davis - Quest Diagnostics Incorporated - CEO, President & Director
Thank you. So good morning, everyone, and thanks for getting up early to join us here. And as always, our safe harbor disclosure that I'm sure you've read 30 times through the conference today or yesterday.
So we're here to talk about 4 things today. One,
Quest Diagnostics Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers